Vanda Pharmaceuticals Inc Strategic Asset Allocation Index
Vanda Pharmaceuticals Inc strategic asset allocation index. Vanda Pharmaceuticals Inc (VNDA) has a Strategic Asset Allocation Index of 0.4% as of June 2023. Strategic assets (PP&E of $2.16 Million plus long-term investments of $-) total $2.16 Million, measured against net assets of $539.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Vanda Pharmaceuticals Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Vanda Pharmaceuticals Inc (2004–2022)
Strategic asset allocation index of Vanda Pharmaceuticals Inc from 2004 to 2022. This chart shows how Vanda Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 19 annual periods from 2004 to 2022. As of June 2023, the index stands at 0.4%, representing strategic assets of $2.16 Million against net assets of $539.90 Million USD. Check VNDA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Vanda Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2004–2022)
Vanda Pharmaceuticals Inc strategic asset allocation index by year from 2004 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Vanda Pharmaceuticals Inc from 2004 to 2022, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Vanda Pharmaceuticals Inc (VNDA) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.5% | $2.57 Million | $2.57 Million | $- | $527.20 Million | ▼ -2.0 pp |
| 2021 | 2.5% | $12.38 Million | $12.38 Million | $- | $504.93 Million | ▲ +1.5 pp |
| 2020 | 0.9% | $4.14 Million | $4.14 Million | $- | $453.27 Million | ▼ 0.0 pp |
| 2019 | 0.9% | $3.86 Million | $3.86 Million | $- | $410.94 Million | ▼ -0.7 pp |
| 2018 | 1.6% | $4.42 Million | $4.42 Million | $- | $275.42 Million | ▼ -2.4 pp |
| 2017 | 4.0% | $5.31 Million | $5.31 Million | $- | $131.39 Million | ▲ +0.2 pp |
| 2016 | 3.8% | $5.01 Million | $5.01 Million | $- | $131.33 Million | ▲ +0.4 pp |
| 2015 | 3.4% | $4.57 Million | $4.57 Million | $- | $133.03 Million | ▲ +1.9 pp |
| 2014 | 1.5% | $2.44 Million | $2.44 Million | $- | $160.82 Million | ▼ -3.5 pp |
| 2013 | 5.0% | $2.20 Million | $2.20 Million | $- | $44.12 Million | ▼ -18.7 pp |
| 2012 | 23.7% | $2.35 Million | $2.35 Million | $- | $9.90 Million | ▼ -36.0 pp |
| 2011 | 59.7% | $19.98 Million | $964.00K | $19.01 Million | $33.47 Million | ▲ +57.2 pp |
| 2010 | 2.5% | $937.00K | $937.00K | $- | $37.73 Million | ▼ -3.2 pp |
| 2009 | 5.7% | $1.32 Million | $1.32 Million | $- | $23.03 Million | ▲ +1.9 pp |
| 2008 | 3.8% | $1.76 Million | $1.76 Million | $- | $46.02 Million | ▲ +2.2 pp |
| 2007 | 1.6% | $1.35 Million | $1.35 Million | $- | $83.73 Million | ▼ -5.3 pp |
| 2006 | 7.0% | $1.86 Million | $1.86 Million | $- | $26.76 Million | ▲ +3.3 pp |
| 2005 | 3.6% | $1.11 Million | $1.11 Million | $- | $30.66 Million | ▼ -4.2 pp |
| 2004 | 7.9% | $1.25 Million | $1.25 Million | $- | $15.94 Million | — |